Arthritogenic alphaviruses: new insights into arthritis and bone pathology

Trends Microbiol. 2015 Jan;23(1):35-43. doi: 10.1016/j.tim.2014.09.005. Epub 2014 Oct 30.

Abstract

Arthritogenic alphaviral infection begins as a febrile illness and often progresses to joint pain and rheumatic symptoms that are described as polyarthritis. Alphaviral arthritis and classical arthritides share many similar cellular and immune mediators involved in their pathogenesis. Recent in vitro and in vivo evidence suggests that bone loss resulting from increased expression of bone resorption mediators may accompany alphaviral infection. In addition, several longitudinal studies have reported more severe and delayed recovery of alphaviral disease in patients with pre-existing arthritic conditions. This review aims to provide insights into alphavirus-induced bone loss and focuses on aspects of disease exacerbation in patients with underlying arthritis and on possible therapeutic targets.

Keywords: Ross River virus; alphavirus; arthritis; bone loss; chikungunya virus; inflammation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Alphavirus / genetics*
  • Animals
  • Arthritis, Infectious / complications
  • Arthritis, Infectious / virology*
  • Bone Resorption / etiology
  • Bone Resorption / pathology*
  • Bone Resorption / virology
  • Disease Models, Animal
  • Humans
  • Inflammation / immunology
  • Inflammation / virology
  • Interleukin-17 / immunology
  • Interleukin-6 / immunology
  • Receptor Activator of Nuclear Factor-kappa B / immunology
  • Risk Factors
  • Th17 Cells / immunology

Substances

  • Interleukin-17
  • Interleukin-6
  • Receptor Activator of Nuclear Factor-kappa B
  • TNFRSF11A protein, human